ACLX - Arcellx, Inc.
114.3
0.250 0.219%
Share volume: 1,294,952
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$114.05
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 02-27-2025 | 05-08-2025 | 11-05-2025 | 02-26-2026 | |
| Cash flow financing | -2.985 M | -10.427 M | -4.658 M | -6.017 M | 543.000 K | 86.100 M | 1.634 M | |
| Other financing cash flows | -2.985 M | -11.073 M | -4.658 M | -6.535 M | 543.000 K | -37.650 M | 1.102 M | |
| Cash flow | -241.704 M | -54.549 M | 61.821 M | -56.167 M | -24.818 M | 16.867 M | 1.257 M | |
| Net income | -7.198 M | -27.202 M | -25.867 M | -47.081 M | -62.270 M | -55.781 M | -58.112 M | |
| Depreciation | 826.000 K | 1.239 M | 1.334 M | 1.789 M | 1.576 M | 1.843 M | 1.641 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -206.812 M | -7.873 M | 35.760 M | -4.120 M | 37.784 M | -20.026 M | 57.798 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 6.432 M | 3.213 M | 2.290 M | 1.499 M | 780.000 K | 296.000 K | 764.000 K | |
| Cash Change | -241.704 M | -54.549 M | 61.821 M | -56.167 M | -24.818 M | 16.867 M | 1.257 M |